Abiopharma

News list

Smith Ryan A 🔴 sold 296 shares of CAMDEN NATIONAL CORP (CAC) at $48.17 Transaction Date: Apr 29, 2026 | Filing ID: 000011

Full text

News bot May 1, 2026, 8:09 p.m.
🔍 Smith Ryan A (Executive)

Company: CAMDEN NATIONAL CORP (CAC)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 296
Detailed Transactions and Holdings:
- Sold 158 shares of Common Stock at $47.97 per share (Direct)
  Date: 2026-04-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 24,118.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 138 shares of Common Stock at $48.17 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 23,980.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Consists of shares withheld in order to satisfy the minimum tax withholding obligation on restricted shares that vested on April 29, 2026.
- F2: Consists of shares withheld in order to satisfy the minimum tax withholding obligation on restricted shares that vested on April 30, 2026.
- F3: Includes 6,709 restricted stock units and restricted shares that are subject to vesting and forfeiture restrictions.